Want to see IL:HMGS full AI Analyst Report?
Homebiogas (HMGS) AI Stock Analysis
Homebiogas
(TASE:HMGS)
The overall score reflects a balance between significant financial risk and modest technical and balance-sheet strengths. The most impactful factor is weak financial performance: recurring net losses, negative operating cash flow, and equity erosion indicate a fragile profitability and capital position despite improving margins and reduced debt. Technicals contribute a slightly positive tilt, with supportive medium-term trend measures and oversold-like momentum suggesting some potential for price stabilization rather than a clear downtrend. Valuation is constrained by negative earnings and the absence of dividends, making the investment case heavily dependent on future operational improvement rather than current fundamentals, which keeps the stock in a high-risk, moderate-score range.
Homebiogas (HMGS) vs. iShares MSCI Israel ETF (EIS)
- Market Cap
- ILS 20.80M
- Dividend Yield
- ―
- Average Volume (3M)
- 136.41K
- Price to Earnings (P/E)
- -1.3
- Beta (1Y)
- 0.04
- Revenue Growth
- -10.23%
- EPS Growth
- 35.34%
- Country
- Israel
- Employees
- 71
- Sector
- General
- Sector Strength
- 55
- Industry
- Renewable Utilities
Homebiogas Business Overview & Revenue Model
Company Description
HomeBiogas LTD develops, produces, and markets innovative biogas systems that convert organic waste into clean energy. These solutions serve a broad international clientele, including private homes, agricultural businesses, commercial entities, and l...
How the Company Makes Money
HomeBiogas primarily makes money by selling physical anaerobic digestion systems (and related equipment) that customers install and use to convert organic waste into usable biogas. Revenue is generated from (1) product sales of its biogas digester un...
Homebiogas Financial Statement Overview
Summary
Financial performance is weak overall, with modest revenue growth and improving gross margins offset by persistent, sizable net losses and negative operating cash flow. The balance sheet shows low leverage and shrinking debt, which is a clear strength, but equity has been eroded by repeated losses and ROE is deeply negative, indicating limited shareholder value creation. Cash burn has improved and free cash flow trends are better aligned with net income, yet the business is still consuming cash rather than generating it, leaving the financial profile high risk despite some signs of stabilization.
Income Statement
35NegativeBalance Sheet
65PositiveCash Flow
45Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.10M | 3.13M | 2.63M | 4.83M | 4.70M | 2.48M |
| Gross Profit | 1.25M | 899.53K | 384.00K | 1.55M | 1.34M | 234.00K |
| EBITDA | -4.44M | -3.76M | -8.23M | -9.91M | -14.00M | -7.64M |
| Net Income | -5.27M | -4.14M | -9.42M | -11.34M | -15.16M | -8.31M |
Balance Sheet | ||||||
| Total Assets | 6.03M | 5.23M | 8.21M | 19.43M | 19.62M | 33.58M |
| Cash, Cash Equivalents and Short-Term Investments | 2.34M | 1.95M | 2.84M | 9.14M | 11.20M | 26.05M |
| Total Debt | 343.00K | 391.08K | 470.00K | 1.95M | 1.64M | 1.99M |
| Total Liabilities | 3.20M | 2.16M | 3.23M | 5.39M | 5.23M | 5.49M |
| Stockholders Equity | 2.81M | 2.79M | 4.93M | 14.04M | 14.39M | 28.09M |
Cash Flow | ||||||
| Free Cash Flow | -3.06M | -2.44M | -5.54M | -11.13M | -12.77M | -10.72M |
| Operating Cash Flow | -3.00M | -2.43M | -4.51M | -10.58M | -11.57M | -8.33M |
| Investing Cash Flow | -10.57K | 169.95K | -847.00K | -571.00K | -1.13M | -2.49M |
| Financing Cash Flow | 2.79M | 1.02M | -639.00K | 9.28M | -419.00K | 28.77M |
Homebiogas Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:HMGS, the sentiment is Negative. The current price of 73.40 is below the 20-day moving average (MA) of 80.91, below the 50-day MA of 81.23, and below the 200-day MA of 80.17, indicating a bearish trend. The MACD of -2.33 indicates Positive momentum. The RSI at 36.23 is Neutral, neither overbought nor oversold. The STOCH value of 13.40 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:HMGS.
Homebiogas Peers Comparison
Overall Rating
IL:ECNR55Neutral- IL:HMGS50Neutral
IL:SBEN47Neutral
IL:MSKE46Neutral
IL:ZPRS39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| IL:ECNR | 55Neutral | ILS 4.51B | -21.84 | ― | ― | 2.40% | -570.07% |
| IL:HMGS | 50Neutral | ILS 32.36M | -1.34 | ― | ― | -10.23% | 35.34% |
| IL:SBEN | 47Neutral | ILS 3.85B | -13.52 | ― | ― | 64.06% | -1059.35% |
| IL:MSKE | 46Neutral | ILS 6.77B | -53.52 | ― | ― | ― | ― |
| IL:ZPRS | 39Underperform | ILS 1.50B | -27.35 | ― | ― | ― | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IL:HMGS | HOMEBIOGAS LTD | 73.40 | -68.10 | -48.13% | |
| IL:MSKE | Meshek Energy Renewable Energies Ltd. | 914.10 | 237.10 | 35.02% | |
| IL:PRIM | Prime Energy P.E. LTD | 3643.00 | 2115.00 | 138.42% | |
| IL:ECNR | Econergy renewable energy Ltd | 5842.00 | 1976.00 | 51.11% | |
| IL:SBEN | SHIKUN & BINUI ENERGY LTD | 393.50 | 106.90 | 37.30% | |
| IL:ZPRS | Zephyrus Wing Energies Ltd. | 2133.00 | 32.00 | 1.52% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 05, 2026